Based on the key indicators obtained from Guardant Health's historical financial statements, Guardant Health may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. As of now, Guardant Health's Non Currrent Assets Other are increasing as compared to previous years. The Guardant Health's current Other Assets is estimated to increase to about 44 M, while Total Assets are projected to decrease to under 1.4 B. Key indicators impacting Guardant Health's financial strength include:
The financial analysis of Guardant Health is a critical element in measuring its lifeblood. Investors should not minimize Guardant Health's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
(455.48 Million)
Guardant
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Investments
Change In Cash
Net Borrowings
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Change To Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Change Receivables
Dividends Paid
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Net Tangible Assets
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Long Term Debt
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Short Term Investments
Long Term Debt Total
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Surpluse
Capital Lease Obligations
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Long Term Investments
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Non Current Liabilities Other
Short Term Debt
Property Plant Equipment
Net Invested Capital
Net Working Capital
Intangible Assets
Warrants
Retained Earnings Total Equity
Tax Provision
Net Interest Income
Interest Income
Depreciation And Amortization
Interest Expense
Selling General Administrative
Selling And Marketing Expenses
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Minority Interest
Reconciled Depreciation
Non Operating Income Net Other
Probability Of Bankruptcy
Understanding current and past Guardant Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Guardant Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Guardant Health's assets may result in an increase in income on the income statement.
Guardant Health competes with Illumina, Twist Bioscience, Natera, Caredx, and Myriad Genetics. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1373 people.
Comparative valuation techniques use various fundamental indicators to help in determining Guardant Health's current stock value. Our valuation model uses many indicators to compare Guardant Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guardant Health competition to find correlations between indicators driving Guardant Health's intrinsic value. More Info.
Guardant Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Guardant Health's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guardant Health's earnings, one of the primary drivers of an investment's value.
Guardant Health's Earnings Breakdown by Geography
Guardant Health Systematic Risk
Guardant Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Guardant Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Guardant Health correlated with the market. If Beta is less than 0 Guardant Health generally moves in the opposite direction as compared to the market. If Guardant Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Guardant Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Guardant Health is generally in the same direction as the market. If Beta > 1 Guardant Health moves generally in the same direction as, but more than the movement of the benchmark.
Guardant Health Thematic Clasifications
Guardant Health is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Guardant Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Guardant Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Guardant Health growth as a starting point in their analysis.
Guardant Health November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Guardant Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Guardant Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Guardant Health based on widely used predictive technical indicators. In general, we focus on analyzing Guardant Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Guardant Health's daily price indicators and compare them against related drivers.
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.